English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease Journal article
Rostam M.A., Piva T.J., Rezaei H.B., Kamato D., Little P.J., Zheng W., Osman N.. Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease[J]. Clinical and Experimental Pharmacology and Physiology, 2015, 42(2), 117-124.
Authors:  Rostam M.A.;  Piva T.J.;  Rezaei H.B.;  Kamato D.;  Little P.J.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:24 | Submit date：2018/12/21
Atherosclerosis  Cardiovascular Disease  Peptidyl-prolyl Isomerase  Pin1  
Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation Journal article
Little P.J., Getachew R., Rezaei H.B., Sanchez-Guerrero E., Khachigian L.M., Wang H., Liao S., Zheng W., Ballinger M.L., Osman N.. Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation[J]. Archives of Biochemistry and Biophysics, 2012, 525(1), 25-31.
Authors:  Little P.J.;  Getachew R.;  Rezaei H.B.;  Sanchez-Guerrero E.;  Khachigian L.M.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:20 | Submit date：2018/12/21
Genistein  Glycosaminoglycans  Pdgf Receptor Phosphorylation  Proteoglycans  Vascular Smooth Muscle